rivastigmine tartrate

Generic: rivastigmine tartrate

Labeler: alembic pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name rivastigmine tartrate
Generic Name rivastigmine tartrate
Labeler alembic pharmaceuticals inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

rivastigmine tartrate 1.5 mg/1

Manufacturer
Alembic Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 62332-063
Product ID 62332-063_0044f1d7-613c-4611-8481-13032c8cb390
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA091689
Listing Expiration 2026-12-31
Marketing Start 2022-06-12

Pharmacologic Class

Classes
cholinesterase inhibitor [epc] cholinesterase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62332063
Hyphenated Format 62332-063

Supplemental Identifiers

RxCUI
312835 312836 314214 314215
UPC
0362332066308 0362332063307
UNII
9IY2357JPE

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name rivastigmine tartrate (source: ndc)
Generic Name rivastigmine tartrate (source: ndc)
Application Number ANDA091689 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 1.5 mg/1
source: ndc
Packaging
  • 100 BLISTER PACK in 1 BOX, UNIT-DOSE (62332-063-10) / 10 CAPSULE in 1 BLISTER PACK
  • 30 CAPSULE in 1 BOTTLE (62332-063-30)
  • 60 CAPSULE in 1 BOTTLE (62332-063-60)
  • 500 CAPSULE in 1 BOTTLE (62332-063-71)
  • 1000 CAPSULE in 1 BOTTLE (62332-063-91)
source: ndc

Packages (5)

62332-063-10 100 BLISTER PACK in 1 BOX, UNIT-DOSE (62332-063-10) / 10 CAPSULE in 1 BLISTER PACK 62332-063-30 30 CAPSULE in 1 BOTTLE (62332-063-30) 62332-063-60 60 CAPSULE in 1 BOTTLE (62332-063-60) 62332-063-71 500 CAPSULE in 1 BOTTLE (62332-063-71) 62332-063-91 1000 CAPSULE in 1 BOTTLE (62332-063-91)

Ingredients (1)

rivastigmine tartrate (1.5 mg/1)

Linked Drug Pages (1)

Rivastigmine Tartrate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "0044f1d7-613c-4611-8481-13032c8cb390", "openfda": {"upc": ["0362332066308", "0362332063307"], "unii": ["9IY2357JPE"], "rxcui": ["312835", "312836", "314214", "314215"], "spl_set_id": ["0044f1d7-613c-4611-8481-13032c8cb390"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 BLISTER PACK in 1 BOX, UNIT-DOSE (62332-063-10)  / 10 CAPSULE in 1 BLISTER PACK", "package_ndc": "62332-063-10", "marketing_start_date": "20220612"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (62332-063-30)", "package_ndc": "62332-063-30", "marketing_start_date": "20220612"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (62332-063-60)", "package_ndc": "62332-063-60", "marketing_start_date": "20220612"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (62332-063-71)", "package_ndc": "62332-063-71", "marketing_start_date": "20220612"}, {"sample": false, "description": "1000 CAPSULE in 1 BOTTLE (62332-063-91)", "package_ndc": "62332-063-91", "marketing_start_date": "20220612"}], "brand_name": "Rivastigmine Tartrate", "product_id": "62332-063_0044f1d7-613c-4611-8481-13032c8cb390", "dosage_form": "CAPSULE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "62332-063", "generic_name": "Rivastigmine Tartrate", "labeler_name": "Alembic Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rivastigmine Tartrate", "active_ingredients": [{"name": "RIVASTIGMINE TARTRATE", "strength": "1.5 mg/1"}], "application_number": "ANDA091689", "marketing_category": "ANDA", "marketing_start_date": "20220612", "listing_expiration_date": "20261231"}